Delving Into Participation Trends of Scleroderma Clinical Trials

N/ANot Yet RecruitingNCT06264492

Power Life Sciences Inc.500 enrolled

Overview

Typically, specific demographic subsets tend to exhibit greater engagement in medical research. Nonetheless, there is insufficient research elucidating the trial characteristics influencing the participation of these particular demographics. The study will analyze data from diverse demographic viewpoints to uncover recurring trends that could provide valuable insights for future patients with scleroderma.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Scleroderma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient has been diagnosed with scleroderma * Patient has self-identified as planning to enroll in an observational clinical trial * Patient is a minimum of 18 years or older Exclusion Criteria: * Patient is pregnant * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form

Locations (1)

Power Life Sciences

San Francisco, California, United States

Outcomes

Primary Outcomes

Rate of patients in clinical research for scleroderma

Time frame: 3 months

Number of scleroderma study participants who stay committed until clinical study wraps up

Time frame: 12 months

Central Contacts

Michael B Gill

CONTACT

4159004227 bask@withpower.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.